Recent News

• 05.07.2026 - NextCure Provides Business Update and Reports First Quarter 2026 Financial Results
• 05.04.2026 - NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers
• 04.21.2026 - NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026
• 04.07.2026 - NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
• 03.31.2026 - NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
• 03.05.2026 - NextCure Provides Business Update and Reports Full Year 2025 Financial Results

Recent Filings

• 05.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.24.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.24.2026 - DEF 14A Other definitive proxy statements
• 03.05.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.05.2026 - EX-99.1 EX-99.1
• 03.05.2026 - 8-K Current report
• 03.05.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.13.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors